参考文献/References:
[1] Fernandes-Rosa FL,Boulkroun S,Fedlaoui B,et al.New advances in endocrine hypertension:from genes to biomarkers [J].Kidney Int,2023,103(3):485-500.DOI:10.1016/j.kint.2022.12.021.
[2] Cerqueira A,Seco T,Costa A,et al.Pheochromocytoma and paraganglioma:a review of diagnosis,management and treatment of rare causes of hypertension [J].Cureus,2020,12(5):e7969.DOI:10.7759/cureus.7969.
[3] 肾上腺意外瘤多学科管理专家组.肾上腺意外瘤多学科管理专家共识 [J].中华内分泌外科杂志,2021,15(04):325-336.DOI:10.3760/cma.j.cn.115807-20210723-00225.
[4] Neumann HPH,Young WF Jr,Eng C.Pheochromocytoma and paraganglioma [J].N Engl J Med,2019,381(6):552-565.DOI:10.1056/NEJMra1806651.
[5] Richter S,Garrett TJ,Bechmann N,et al.Metabolomics in paraganglioma:applications and perspectives from genetics to therapy [J].Endocr Relat Cancer,2023,30(6):e220376.DOI:10.1530/ERC-22-0376.
[6] Nishikawa T,Omura M,Satoh F,et al; Task Force Committee on Primary Aldosteronism,The Japan Endocrine Society.Guidelines for the diagnosis and treatment of primary aldosteronism—the Japan Endocrine Society 2009 [J].Endocr J,2011,58(9):711-721.DOI:10.1507/endocrj.ej11-0133.
[7] Young WF Jr.Diagnosis and treatment of primary aldosteronism:practical clinical perspectives [J]. J Intern Med,2019,285(2):126-148.DOI:10.1111/joim.12831.
[8] Naruse M,Murakami M,Katabami T,et al.International multicenter survey on screening and confirmatory testing in primary aldosteronism [J].Eur J Endocrinol,2023,188(1):lvac002.DOI:10.1093/ejendo/lvac002.
[9] Young WF Jr,Calhoun DA,Lenders JWM,et al.Screening for endocrine hypertension:an endocrine society scientific statement [J].Endocrine Reviews,2017,38(2):103-22.DOI:10.1210/er.2017-00054.
[10] Artyszuk ,Symonides B,Gaciong Z,et al.A new threshold for kidney asymmetry improves association with abnormal renal-aortic ratio for diagnosis of renal artery stenosis [J].Vasc Med,2022,27(6):551-556.DOI:10.1177/1358863X221118604.
[11] Claahsen-van der Grinten HL,Speiser PW,Ahmed SF,et al.Congenital adrenal hyperplasia-current insights in pathophysiology,diagnostics,and management [J].Endocr Rev,2022,43(1):91-159.DOI:10.1210/endrev/bnab016.
[12] Jiang S,Chen X,Wu Y,et al.An update on silent corticotroph adenomas:diagnosis,mechanisms,clinical features,and management [J].Cancers(Basel),2021,13(23):6134.DOI:10.3390/cancers13236134.
[13] Galm BP,Qiao N,Klibanski A,et al.Accuracy of laboratory tests for the diagnosis of Cushing syndrome [J].J Clin Endocrinol Metab,2020,105(6):2081-2094.DOI:10.1210/clinem/dgaa105.
[14] Scaroni C,Albiger NM,Palmieri S,et al.Approach to patients with pseudo-Cushing's states[J].Endocr Connect,2020,9(1):R1-R13.DOI:10.1530/EC-19-0435.
[15] Lu YT,Zhang D,Zhang QY,et al.Apparent mineralocorticoid excess:comprehensive overview of molecular genetics [J].J Transl Med,2022,20(1):500.DOI:10.1186/s12967-022-03698-9.
[16] Wang X,Cao C,Yao Q,et al.A family with liddle syndrome caused by a novel stop-gain mutation in the γ subunit of epithelial sodium channels [J].Nephron,2022,146(6):647-651.DOI:10.1159/000525002.
[17] Brown J,Yazdi F,Jodari-Karimi M,et al.Obstructive sleep apnea and hypertension:updates to a critical relationship [J].Curr Hypertens Rep,2022,24(6):173-184.DOI:10.1007/s11906-022-01181-w.
[18] Fleseriu M,Langlois F,Lim DST,et al.Acromegaly:pathogenesis,diagnosis,and management [J].Lancet Diabetes Endocrinol,2022,10(11):804-826.DIO:10.1016/S2213-8587(22)00244-3.
[19] Rivas AM,Pena C,Kopel J,et al.Hypertension and hyperthyroidism:association and pathogenesis [J].Am J Med Sci,2021,361(1):3-7.DOI:10.1016/j.amjms.2020.08.012.
[20] Fisher SB,Perrier ND.Primary hyperparathyroidism and hypertension [J].Gland Surg,2020,9(1):142-9.DOI:10.21037/gs.2019.10.21.
相似文献/References:
[1]韩菲,杨立成,孙红喜,等.2型糖尿病合并不同分期慢性肾脏疾病患者的血压特点[J].国际内分泌代谢杂志,2015,(03):149.[doi:10.3760/cma.j.issn.1673-4157.2015.03.002]
Han Fei*,Yang Licheng,Sun Hongxi,et al.Characteristics of blood pressure in type 2 diabetic patients with different degree of chronic kidney disease[J].International Journal of Endocrinology and Metabolism,2015,(06):149.[doi:10.3760/cma.j.issn.1673-4157.2015.03.002]
[2]时磊,王莉,梁声茹,等.青中年时期体重状态变化与中老年时期高血压的关系[J].国际内分泌代谢杂志,2021,41(02):100.[doi:10.3760/cma.j.cn121383-20200625-06078]
Shi Lei,Wang Li,Liang Shengru,et al.Relationship between changes of body weight status in young and middle-aged and hypertension in middle-aged and elderly people[J].International Journal of Endocrinology and Metabolism,2021,41(06):100.[doi:10.3760/cma.j.cn121383-20200625-06078]
[3]樊淑娟,代青湘.高血压与骨质疏松症相关机制研究进展[J].国际内分泌代谢杂志,2023,43(06):489.[doi:10.3760/cma.j.cn121383-20220511-05019]
Fan Shujuan,Dai Qingxiang..Research progress on the correlation mechanism between hypertension and osteoporosis[J].International Journal of Endocrinology and Metabolism,2023,43(06):489.[doi:10.3760/cma.j.cn121383-20220511-05019]